The history of cyclodextrins / / edited by Grégorio Crini, Sophie Fourmentin, Eric Lichtfouse |
Edizione | [1st ed. 2020.] |
Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2020] |
Descrizione fisica | 1 online resource (XIV, 401 p. 135 illus., 84 illus. in color.) |
Disciplina | 572.565 |
Collana | Environmental Chemistry for a Sustainable World |
Soggetto topico | Cyclodextrins |
ISBN | 3-030-49308-3 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Preface -- Chapter 1 History of Cyclodextrins -- Chapter 2 Professor József Szejtli: The Godfather of Cyclodextrins -- Chapter 3 Professor Casu and Cyclodextrins -- Chapter 4 History of Cyclodextrin Production in Hungary -- Chapter 5 Metal Nanoparticles and Cyclodextrins for Catalytic Applications -- Chapter 6 Cyclodextrin-Based Polymers for Food and Pharmaceutical Applications: A Historical Review -- Chapter 7 Role of Cyclodextrins in Nanoparticle-Based Systems for Drug Delivery -- Chapter 8 Water-Insoluble Cyclodextrin-Epichlorohydrin Polymers. |
Record Nr. | UNINA-9910768175303321 |
Cham, Switzerland : , : Springer, , [2020] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Iminosugars [[electronic resource] ] : from synthesis to therapeutic applications / / editors, Philippe Compain and Olivier R. Martin |
Pubbl/distr/stampa | Chichester, West Sussex, England ; ; Hoboken, NJ, USA, : J. Wiley, c2007 |
Descrizione fisica | 1 online resource (487 p.) |
Disciplina |
572.565
612/.01578 |
Altri autori (Persone) |
CompainPhilippe
MartinOlivier R |
Soggetto topico |
Imino sugars - Synthesis
Imino sugars - Therapeutic use |
ISBN |
1-281-13531-3
9786611135317 0-470-51743-3 0-470-51744-1 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Iminosugars; Contents; Foreword; Preface; List of contributors; 1 Iminosugars: past, present and future; 2 Naturally occurring iminosugars and related alkaloids: structure, activity and applications; 2.1 Introduction; 2.2 -Glucosidase inhibitors; 2.3 -Glucosidase inhibitors; 2.4 - and -Galactosidase inhibitors; 2.5 -Mannosidase inhibitors; 2.6 Concluding remarks and future prospects; References; 3 General strategies for the synthesis of iminosugars and new approaches towards iminosugar libraries; 3.1 Introduction; 3.2 Monocyclic compounds; 3.3 1-N-Iminosugars; 3.4 Bicyclic compounds
3.5 Other bicyclic compounds3.6 Iminosugar conjugates; 3.7 Conclusions; References; 4 Iminosugar C-glycosides: synthesis and biological activity; 4.1 Introduction; 4.2 Synthesis of iminosugar C-glycosides; 4.3 Biological activity of iminosugar C-glycosides; 4.4 Conclusion; References; 5 Imino-C-disaccharides and analogues: synthesis and biological activity; 5.1 Introduction; 5.2 Synthesis of imino-C-disaccharides; 5.3 Conformations of imino-C-disaccharides; 5.4 Glycosidase inhibitory activities of imino-C-disaccharides 5.5 Efficient combinatorial method for the discovery of glycosidase inhibitors5.6 Antitumour activity of new -mannosidase inhibitors; 5.7 Conclusion; References; 6 Isofagomine, noeuromycin and other 1-azasugars, iminosugar-related glycosidase inhibitors; 6.1 Introduction; 6.2 1-Azasugars that are piperidines (isofagomine, noeuromycin, etc.); 6.3 1-Azasugars that are hydrazines; 6.4 1-Azasugars that are oxazines; 6.5 1-Azasugars that are piperidones; 6.6 Sulphur-containing analogues of 1-azasugars; 6.7 Slow inhibition and thermodynamics of binding 6.8 Are 1-azasugars (and iminosugars) transition state analogues?References; 7 Iminosugar-based glycosyltransferase inhibitors; 7.1 Biological role and structural features of glycosyltransferases; 7.2 Development of inhibitors of glycosyltransferases; 7.3 Conclusion; References; 8 Transition state analogue inhibitors of N-ribosyltransferases; 8.1 Introduction; 8.2 Nucleoside hydrolases; 8.3 Purine nucleoside phosphorylases (PNPs); 8.4 5'-Methylthioadenosine (MTA) nucleosidases and phosphorylases; 8.5 Ricin A-chain; References; 9 Iminosugars as antiviral agents; 9.1 Introduction 9.2 The relationship between glucosidase inhibition and antiviral action9.3 Fate of viral glycoproteins in glucosidase-inhibited cells; 9.4 Specificity of glucosidase inhibition; 9.5 N-Alkyl DNJs inhibit virus growth by non-glucosidase inhibitory mechanisms - other potential activities of these compounds; 9.6 New directions for improving glucosidase inhibitors as antiviral agents; References; 10 Iminosugars as active-site-specific chaperones for the treatment of lysosomal storage disorders; 10.1 Introduction; 10.2 Degradation of glycosphingolipids 10.3 Lysosomal enzyme biosynthesis and ER-associated degradation (ERAD) |
Record Nr. | UNINA-9910145735503321 |
Chichester, West Sussex, England ; ; Hoboken, NJ, USA, : J. Wiley, c2007 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Iminosugars [[electronic resource] ] : from synthesis to therapeutic applications / / editors, Philippe Compain and Olivier R. Martin |
Pubbl/distr/stampa | Chichester, West Sussex, England ; ; Hoboken, NJ, USA, : J. Wiley, c2007 |
Descrizione fisica | 1 online resource (487 p.) |
Disciplina |
572.565
612/.01578 |
Altri autori (Persone) |
CompainPhilippe
MartinOlivier R |
Soggetto topico |
Imino sugars - Synthesis
Imino sugars - Therapeutic use |
ISBN |
1-281-13531-3
9786611135317 0-470-51743-3 0-470-51744-1 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Iminosugars; Contents; Foreword; Preface; List of contributors; 1 Iminosugars: past, present and future; 2 Naturally occurring iminosugars and related alkaloids: structure, activity and applications; 2.1 Introduction; 2.2 -Glucosidase inhibitors; 2.3 -Glucosidase inhibitors; 2.4 - and -Galactosidase inhibitors; 2.5 -Mannosidase inhibitors; 2.6 Concluding remarks and future prospects; References; 3 General strategies for the synthesis of iminosugars and new approaches towards iminosugar libraries; 3.1 Introduction; 3.2 Monocyclic compounds; 3.3 1-N-Iminosugars; 3.4 Bicyclic compounds
3.5 Other bicyclic compounds3.6 Iminosugar conjugates; 3.7 Conclusions; References; 4 Iminosugar C-glycosides: synthesis and biological activity; 4.1 Introduction; 4.2 Synthesis of iminosugar C-glycosides; 4.3 Biological activity of iminosugar C-glycosides; 4.4 Conclusion; References; 5 Imino-C-disaccharides and analogues: synthesis and biological activity; 5.1 Introduction; 5.2 Synthesis of imino-C-disaccharides; 5.3 Conformations of imino-C-disaccharides; 5.4 Glycosidase inhibitory activities of imino-C-disaccharides 5.5 Efficient combinatorial method for the discovery of glycosidase inhibitors5.6 Antitumour activity of new -mannosidase inhibitors; 5.7 Conclusion; References; 6 Isofagomine, noeuromycin and other 1-azasugars, iminosugar-related glycosidase inhibitors; 6.1 Introduction; 6.2 1-Azasugars that are piperidines (isofagomine, noeuromycin, etc.); 6.3 1-Azasugars that are hydrazines; 6.4 1-Azasugars that are oxazines; 6.5 1-Azasugars that are piperidones; 6.6 Sulphur-containing analogues of 1-azasugars; 6.7 Slow inhibition and thermodynamics of binding 6.8 Are 1-azasugars (and iminosugars) transition state analogues?References; 7 Iminosugar-based glycosyltransferase inhibitors; 7.1 Biological role and structural features of glycosyltransferases; 7.2 Development of inhibitors of glycosyltransferases; 7.3 Conclusion; References; 8 Transition state analogue inhibitors of N-ribosyltransferases; 8.1 Introduction; 8.2 Nucleoside hydrolases; 8.3 Purine nucleoside phosphorylases (PNPs); 8.4 5'-Methylthioadenosine (MTA) nucleosidases and phosphorylases; 8.5 Ricin A-chain; References; 9 Iminosugars as antiviral agents; 9.1 Introduction 9.2 The relationship between glucosidase inhibition and antiviral action9.3 Fate of viral glycoproteins in glucosidase-inhibited cells; 9.4 Specificity of glucosidase inhibition; 9.5 N-Alkyl DNJs inhibit virus growth by non-glucosidase inhibitory mechanisms - other potential activities of these compounds; 9.6 New directions for improving glucosidase inhibitors as antiviral agents; References; 10 Iminosugars as active-site-specific chaperones for the treatment of lysosomal storage disorders; 10.1 Introduction; 10.2 Degradation of glycosphingolipids 10.3 Lysosomal enzyme biosynthesis and ER-associated degradation (ERAD) |
Record Nr. | UNINA-9910830224103321 |
Chichester, West Sussex, England ; ; Hoboken, NJ, USA, : J. Wiley, c2007 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Iminosugars [[electronic resource] ] : from synthesis to therapeutic applications / / editors, Philippe Compain and Olivier R. Martin |
Pubbl/distr/stampa | Chichester, West Sussex, England ; ; Hoboken, NJ, USA, : J. Wiley, c2007 |
Descrizione fisica | 1 online resource (487 p.) |
Disciplina |
572.565
612/.01578 |
Altri autori (Persone) |
CompainPhilippe
MartinOlivier R |
Soggetto topico |
Imino sugars - Synthesis
Imino sugars - Therapeutic use |
ISBN |
1-281-13531-3
9786611135317 0-470-51743-3 0-470-51744-1 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Iminosugars; Contents; Foreword; Preface; List of contributors; 1 Iminosugars: past, present and future; 2 Naturally occurring iminosugars and related alkaloids: structure, activity and applications; 2.1 Introduction; 2.2 -Glucosidase inhibitors; 2.3 -Glucosidase inhibitors; 2.4 - and -Galactosidase inhibitors; 2.5 -Mannosidase inhibitors; 2.6 Concluding remarks and future prospects; References; 3 General strategies for the synthesis of iminosugars and new approaches towards iminosugar libraries; 3.1 Introduction; 3.2 Monocyclic compounds; 3.3 1-N-Iminosugars; 3.4 Bicyclic compounds
3.5 Other bicyclic compounds3.6 Iminosugar conjugates; 3.7 Conclusions; References; 4 Iminosugar C-glycosides: synthesis and biological activity; 4.1 Introduction; 4.2 Synthesis of iminosugar C-glycosides; 4.3 Biological activity of iminosugar C-glycosides; 4.4 Conclusion; References; 5 Imino-C-disaccharides and analogues: synthesis and biological activity; 5.1 Introduction; 5.2 Synthesis of imino-C-disaccharides; 5.3 Conformations of imino-C-disaccharides; 5.4 Glycosidase inhibitory activities of imino-C-disaccharides 5.5 Efficient combinatorial method for the discovery of glycosidase inhibitors5.6 Antitumour activity of new -mannosidase inhibitors; 5.7 Conclusion; References; 6 Isofagomine, noeuromycin and other 1-azasugars, iminosugar-related glycosidase inhibitors; 6.1 Introduction; 6.2 1-Azasugars that are piperidines (isofagomine, noeuromycin, etc.); 6.3 1-Azasugars that are hydrazines; 6.4 1-Azasugars that are oxazines; 6.5 1-Azasugars that are piperidones; 6.6 Sulphur-containing analogues of 1-azasugars; 6.7 Slow inhibition and thermodynamics of binding 6.8 Are 1-azasugars (and iminosugars) transition state analogues?References; 7 Iminosugar-based glycosyltransferase inhibitors; 7.1 Biological role and structural features of glycosyltransferases; 7.2 Development of inhibitors of glycosyltransferases; 7.3 Conclusion; References; 8 Transition state analogue inhibitors of N-ribosyltransferases; 8.1 Introduction; 8.2 Nucleoside hydrolases; 8.3 Purine nucleoside phosphorylases (PNPs); 8.4 5'-Methylthioadenosine (MTA) nucleosidases and phosphorylases; 8.5 Ricin A-chain; References; 9 Iminosugars as antiviral agents; 9.1 Introduction 9.2 The relationship between glucosidase inhibition and antiviral action9.3 Fate of viral glycoproteins in glucosidase-inhibited cells; 9.4 Specificity of glucosidase inhibition; 9.5 N-Alkyl DNJs inhibit virus growth by non-glucosidase inhibitory mechanisms - other potential activities of these compounds; 9.6 New directions for improving glucosidase inhibitors as antiviral agents; References; 10 Iminosugars as active-site-specific chaperones for the treatment of lysosomal storage disorders; 10.1 Introduction; 10.2 Degradation of glycosphingolipids 10.3 Lysosomal enzyme biosynthesis and ER-associated degradation (ERAD) |
Record Nr. | UNINA-9910840556703321 |
Chichester, West Sussex, England ; ; Hoboken, NJ, USA, : J. Wiley, c2007 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Lactose and lactose derivatives / / Néstor Gutiérrez-Méndez, editor |
Pubbl/distr/stampa | [Place of publication not identified] : , : IntechOpen, , [2020] |
Descrizione fisica | 1 online resource (104 pages) : illustrations |
Disciplina | 572.565 |
Soggetto topico |
Lactose
Lactose in the body Lactose intolerance |
ISBN | 1-83962-605-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910431358703321 |
[Place of publication not identified] : , : IntechOpen, , [2020] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Lactose and Lactose Derivatives / / edited by Néstor Gutiérrez-Méndez |
Pubbl/distr/stampa | London : , : IntechOpen, , 2020 |
Descrizione fisica | 1 online resource (75 pages) |
Disciplina | 572.565 |
Soggetto topico | Lactose |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910688437703321 |
London : , : IntechOpen, , 2020 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|